The Cost of Dementia in the US in 2026

The Journal of the Alzheimer's Association recently published an artricle on the cost of dementia in the United States. You can find the full article here. We summarized it below:

This report estimates the 2026 societal and economic costs of dementia in the United States, highlighting the burden on individuals, families, and health systems.

Conclusion

The study highlights dementia’s profound economic and quality-of-life toll, primarily borne by families, and calls for policy reforms to expand support and improve care outcomes.

Prevalence and Population Characteristics

• An estimated 5.7 million adults aged 51+ live with dementia in 2026, mostly aged 65+.

• About 5.2 million care partners support these individuals, primarily family members and spouses.

• The typical dementia patient is around 70 years old, with over half being female and a significant portion having comorbid health conditions.

  
  

Main Cost Components

• Total societal cost: approximately $818 billion, with a confidence interval of $759–866 billion.

• Medical and long-term care costs: about $222 billion, mainly paid by Medicare and Medicaid.

• Unpaid care from families and friends: valued at roughly $237 billion.

• Quality-of-life losses: the largest driver, estimated at $320 billion for persons with dementia and $15 billion for care partners.

• Earnings losses: around $23 billion total, with $14 billion from persons with dementia and $9 billion from caregivers.

Distribution of Costs

• Families bear over 80% of costs, including unpaid care, out-of-pocket expenses, and quality-of-life impacts.

• Government programs cover about 70% of healthcare costs, primarily through Medicare and Medicaid.

• Racial and ethnic disparities exist, with Black and Hispanic populations representing a larger share of the dementia burden but lower formal healthcare utilization, indicating reliance on unpaid care.

Implications and Policy Insights

• The substantial quality-of-life and economic impacts underscore the need for better support for families and caregivers.

• Current policies inadequately address caregiver burden and out-of-pocket costs.

• Advances in treatment and care models could reduce caregiver burden and improve quality of life, potentially altering future costs.

• The methodology supports evaluating how prevention, treatment, and policy changes influence costs over time.